These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10930668)

  • 1. Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.
    Levenbook I; Dragunsky E; Pervikovc Y
    Vaccine; 2000 Sep; 19(2-3):163-6. PubMed ID: 10930668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.
    Dragunsky E; Nomura T; Karpinski K; Furesz J; Wood DJ; Pervikov Y; Abe S; Kurata T; Vanloocke O; Karganova G; Taffs R; Heath A; Ivshina A; Levenbook I
    Bull World Health Organ; 2003; 81(4):251-60. PubMed ID: 12764491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TgPVR21 mice for testing type-3 oral poliovirus vaccines: role of clinical observation and histological examination.
    Dragunsky E; Chernokhvostova Y; Taffs R; Chumakov K; Gardner D; Asher D; Nomura T; Hioki K; Levenbook I
    Vaccine; 1997 Dec; 15(17-18):1863-6. PubMed ID: 9413095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J; Contreras G
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
    Dragunsky E; Taffs R; Chernokhvostova Y; Nomura T; Hioki K; Gardner D; Norwood L; Levenbook I
    Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J; Levenbook I
    Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells.
    Horie H; Miyazawa M; Ota Y; Wakabayashi K; Yoshida H; Doi Y; Hashizume S
    Vaccine; 2001 Jan; 19(11-12):1456-9. PubMed ID: 11163668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of OPV vaccines by the monkey neurovirulence test: why and how to qualify the experts in histology of central nervous system.
    Poirier B; Morgeaux S; Fuchs F
    Vaccine; 2002 Nov; 21(1-2):115-9. PubMed ID: 12443669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovirulence.
    Wood D
    Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.
    Chumakov KM; Powers LB; Noonan KE; Roninson IB; Levenbook IS
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):199-203. PubMed ID: 1846038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988.
    Nathanson N; Horn SD
    Vaccine; 1992; 10(7):469-74. PubMed ID: 1609550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.
    Dragunsky E; Gardner D; Taffs R; Levenbook I
    Biologicals; 1993 Sep; 21(3):233-7. PubMed ID: 8117436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.
    Vaccine; 1997 Mar; 15(4):341-5. PubMed ID: 9141201
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
    Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
    J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience in Canada with the new revised monkey neurovirulence test for oral poliovirus vaccine.
    Contreras G; Furesz J; Karpinski K; Grinwich K; Gardell C
    J Biol Stand; 1988 Jul; 16(3):195-205. PubMed ID: 2844825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
    Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
    Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.